最終更新日：2022/12/24
We investigated if plasma levels of carboxymethyl-lysine, S100A12 and endosecretory RAGE (esRAGE) were associated with two endpoints: survival without development of PAD and survival without amputation in a 12 years prospective population-based cohort of 146 patients with type 2 diabetes, free from PAD at inclusion.
編集履歴（0）
元となった例文
We
investigated
if
plasma
levels
of
carboxymethyl-lysine,
S100A12
and
endosecretory
RAGE
(esRAGE)
were
associated
with
two
endpoints:
survival
without
development
of
PAD
and
survival
without
amputation
in
a
12
years
prospective
population-based
cohort
of
146
patients
with
type
2
diabetes,
free
from
PAD
at
inclusion.
